Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TROPICAL study of transdermal diclofenac for cancer pain in gastrointestinal cancers
jRCTs051260173Recruiting
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of diclofenac in cancer pain, sponsored by Hisamitsu Pharmaceutical Co., Inc. Primary endpoint: Primary efficacy endpoint. Started Sep 2026; status: recruiting.
02
Drugs
diclofenac
03
Conditions
cancer pain
Beyond the preview
Go deeper on jRCTs051260173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051260173.